Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,172 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Uteroplacental blood flow, cardiac function, and pregnancy outcome in women with congenital heart disease.
Pieper PG, Balci A, Aarnoudse JG, Kampman MA, Sollie KM, Groen H, Mulder BJ, Oudijk MA, Roos-Hesselink JW, Cornette J, van Dijk AP, Spaanderman ME, Drenthen W, van Veldhuisen DJ; ZAHARA II investigators. Pieper PG, et al. Among authors: van dijk ap, van veldhuisen dj. Circulation. 2013 Dec 3;128(23):2478-87. doi: 10.1161/CIRCULATIONAHA.113.002810. Epub 2013 Nov 5. Circulation. 2013. PMID: 24192800
Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population.
Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, Gans RO, Janssen WM, Grobbee DE, de Jong PE; Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group. Hillege HL, et al. Among authors: van gilst wh, van veldhuisen dj. Circulation. 2002 Oct 1;106(14):1777-82. doi: 10.1161/01.cir.0000031732.78052.81. Circulation. 2002. PMID: 12356629
Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria.
Asselbergs FW, Diercks GF, Hillege HL, van Boven AJ, Janssen WM, Voors AA, de Zeeuw D, de Jong PE, van Veldhuisen DJ, van Gilst WH; Prevention of Renal and Vascular Endstage Disease Intervention Trial (PREVEND IT) Investigators. Asselbergs FW, et al. Among authors: van gilst wh, van boven aj, van veldhuisen dj. Circulation. 2004 Nov 2;110(18):2809-16. doi: 10.1161/01.CIR.0000146378.65439.7A. Epub 2004 Oct 18. Circulation. 2004. PMID: 15492322 Clinical Trial.
Outcome of pregnancy in patients after repair of aortic coarctation.
Vriend JW, Drenthen W, Pieper PG, Roos-Hesselink JW, Zwinderman AH, van Veldhuisen DJ, Mulder BJ. Vriend JW, et al. Among authors: van veldhuisen dj. Eur Heart J. 2005 Oct;26(20):2173-8. doi: 10.1093/eurheartj/ehi338. Epub 2005 Jun 9. Eur Heart J. 2005. PMID: 15946957
Cardiac complications relating to pregnancy and recurrence of disease in the offspring of women with atrioventricular septal defects.
Drenthen W, Pieper PG, van der Tuuk K, Roos-Hesselink JW, Voors AA, Mostert B, Mulder BJ, Moons P, Ebels T, van Veldhuisen DJ; Zahara Investigators. Drenthen W, et al. Among authors: van der tuuk k, van veldhuisen dj. Eur Heart J. 2005 Dec;26(23):2581-7. doi: 10.1093/eurheartj/ehi439. Epub 2005 Aug 17. Eur Heart J. 2005. PMID: 16107486
Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure.
van der Meer P, Lipsic E, Westenbrink BD, van de Wal RM, Schoemaker RG, Vellenga E, van Veldhuisen DJ, Voors AA, van Gilst WH. van der Meer P, et al. Among authors: van de wal rm, van gilst wh, van veldhuisen dj. Circulation. 2005 Sep 20;112(12):1743-7. doi: 10.1161/CIRCULATIONAHA.105.549121. Circulation. 2005. PMID: 16172283
Obstetric complications in Marfan syndrome.
Meijboom LJ, Drenthen W, Pieper PG, Groenink M, van der Post JA, Timmermans J, Voors AA, Roos-Hesselink JW, van Veldhuisen DJ, Mulder BJ; ZAHARA investigators. Meijboom LJ, et al. Among authors: van der post ja, van veldhuisen dj. Int J Cardiol. 2006 Jun 7;110(1):53-9. doi: 10.1016/j.ijcard.2005.07.017. Epub 2005 Oct 19. Int J Cardiol. 2006. PMID: 16236373
Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.
Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJ, Yusuf S, Granger CB, Michelson EL, Ostergren J, Cornel JH, de Zeeuw D, Pocock S, van Veldhuisen DJ; Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators. Hillege HL, et al. Among authors: van veldhuisen dj. Circulation. 2006 Feb 7;113(5):671-8. doi: 10.1161/CIRCULATIONAHA.105.580506. Circulation. 2006. PMID: 16461840
1,172 results